Idioma:

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease

Moreira, Otacilio C ; Fernandes, Alice Gomes ; Gomes, Natalia Lins da Silva ; Dos Santos, Carolina Messias ; Jacomasso, Thiago ; Costa, Alexandre Dias Tavares ; Nascimento, Lucas de O Rossetti ; Hasslocher-Moreno, Alejandro Marcel ; do Brasil, Pedro Emmanuel Alvarenga Americano ; Morello, Luis Gustavo ; Marchini, Fabricio Klerynton ; Krieger, Marco Aurelio ; Britto, Constança

Life (Basel, Switzerland), 2023-05, Vol.13 (6), p.1236 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por

Enviar para

Título:
Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
Autor: Moreira, Otacilio C ; Fernandes, Alice Gomes ; Gomes, Natalia Lins da Silva ; Dos Santos, Carolina Messias ; Jacomasso, Thiago ; Costa, Alexandre Dias Tavares ; Nascimento, Lucas de O Rossetti ; Hasslocher-Moreno, Alejandro Marcel ; do Brasil, Pedro Emmanuel Alvarenga Americano ; Morello, Luis Gustavo ; Marchini, Fabricio Klerynton ; Krieger, Marco Aurelio ; Britto, Constança
Assuntos: Biomarkers ; Blood ; Chagas disease ; Clinical trials ; Congenital diseases ; Diagnosis ; Enzymes ; Equivalence ; Genetic testing ; Infections ; International standards ; Manufacturers ; molecular diagnostics ; NAT Chagas ; Nucleic acids ; parasite load ; Parasites ; Patients ; Performance evaluation ; Polymerase chain reaction ; Protozoa ; Reagents ; Real time ; real-time PCR ; Satellite DNA ; Serology ; Trypanosoma cruzi ; Vector-borne diseases
É parte de: Life (Basel, Switzerland), 2023-05, Vol.13 (6), p.1236
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: In the absence of validated biomarkers to control the cure of Chagas disease, PCR-based diagnosis is being used as the main tool for an early indication of therapeutic failure. However, since it is considered a technique of complex reproducibility, mainly due to difficulties in establishing accurate controls to guarantee the quality of the reaction, the use of PCR for Chagas disease diagnosis is restricted to specialized centers. In an effort to disseminate the molecular diagnosis of Chagas disease and its applications, new diagnostic kits based on qPCR have been made available in the market in recent years. Here, we show the results of the validation of the NAT Chagas kit (Nucleic Acid Test for Chagas Disease) for the detection and quantification of in blood samples of patients suspected of Chagas disease infection. The kit, composed of a TaqMan duplex reaction targeting the satellite nuclear DNA and an exogenous internal amplification control, presented a reportable range from 10 to 0.5 parasite equivalents/mL and a limit of detection (LOD) of 0.16 parasite equivalents/mL of blood. In addition, the NAT Chagas kit detected belonging to all six discrete typing units (DTUs-TcI to TcVI), similarly to the in-house real-time PCR performed with commercial reagents, which has been selected as the best performance assay in the international consensus for the validation of qPCR for Chagas disease. In the clinical validation presented here, the kit showed 100% sensitivity and 100% specificity when compared to the consensus in-house real-time PCR assay. Thus, the NAT Chagas kit, which is produced entirely in Brazil under the international standards of good manufacturing practices (GMP), appears as an excellent alternative to enable the molecular diagnosis of Chagas disease in public and private diagnostic centers, as well as to facilitate the monitoring of patients under etiological treatment participating in clinical trials.
Editor: Switzerland: MDPI AG
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease

Switzerland: MDPI AG

Buscando em bases de dados remotas. Favor aguardar.